J. Sjef Verbeek

10.6k total citations · 1 hit paper
129 papers, 7.9k citations indexed

About

J. Sjef Verbeek is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, J. Sjef Verbeek has authored 129 papers receiving a total of 7.9k indexed citations (citations by other indexed papers that have themselves been cited), including 81 papers in Immunology, 75 papers in Radiology, Nuclear Medicine and Imaging and 44 papers in Molecular Biology. Recurrent topics in J. Sjef Verbeek's work include Monoclonal and Polyclonal Antibodies Research (74 papers), T-cell and B-cell Immunology (41 papers) and Glycosylation and Glycoproteins Research (24 papers). J. Sjef Verbeek is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (74 papers), T-cell and B-cell Immunology (41 papers) and Glycosylation and Glycoproteins Research (24 papers). J. Sjef Verbeek collaborates with scholars based in Netherlands, United States and United Kingdom. J. Sjef Verbeek's co-authors include Frans M.A. Hofhuis, J. Engelbert Gessner, Jan G. J. van de Winkel, Ferry Ossendorp, Reinhold Schmidt, Takashi Saito, Wouter L. W. Hazenbos, P J Capel, Ingmar Heijnen and Dirk Meyer and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

J. Sjef Verbeek

129 papers receiving 7.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Arthritis Critically Dependent on Innate Immune System Players

2002 563 citations Hong Ji, Koichiro Ohmura et al. Immunity profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J. Sjef Verbeek Netherlands	52	4.8k	2.8k	2.5k	844	739	129	7.9k
Silvia Bolland United States	42	5.6k 1.2×	2.1k 0.8×	2.7k 1.1×	745 0.9×	410 0.6×	80	8.2k
David C. Wraith United Kingdom	52	6.2k 1.3×	1.3k 0.5×	1.6k 0.7×	1.1k 1.3×	744 1.0×	166	9.4k
Jérry Y. Niederkorn United States	60	4.5k 0.9×	3.3k 1.2×	2.6k 1.0×	884 1.0×	836 1.1×	295	12.2k
Marie Kosco‐Vilbois Switzerland	50	5.8k 1.2×	1.0k 0.4×	2.1k 0.8×	1.4k 1.6×	614 0.8×	142	8.9k
Daisuke Kitamura Japan	47	6.4k 1.3×	979 0.4×	3.2k 1.3×	1.3k 1.5×	639 0.9×	148	9.8k
Iqbal S. Grewal United States	56	7.7k 1.6×	1.3k 0.5×	2.0k 0.8×	2.3k 2.8×	690 0.9×	125	10.8k
Robert A. Eisenberg United States	50	6.6k 1.4×	2.7k 1.0×	2.1k 0.8×	853 1.0×	549 0.7×	180	9.6k
Timo K. van den Berg Netherlands	57	6.0k 1.2×	909 0.3×	3.1k 1.2×	1.1k 1.3×	669 0.9×	157	10.7k
G. J. Thorbecke United States	46	4.7k 1.0×	1.2k 0.4×	1.7k 0.7×	977 1.2×	643 0.9×	268	7.9k
Thierry Defrance France	42	4.6k 1.0×	742 0.3×	1.3k 0.5×	962 1.1×	433 0.6×	85	6.7k

Countries citing papers authored by J. Sjef Verbeek

Since Specialization

Citations

This map shows the geographic impact of J. Sjef Verbeek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Sjef Verbeek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Sjef Verbeek more than expected).

Fields of papers citing papers by J. Sjef Verbeek

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Sjef Verbeek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Sjef Verbeek. The network helps show where J. Sjef Verbeek may publish in the future.

Co-authorship network of co-authors of J. Sjef Verbeek

This figure shows the co-authorship network connecting the top 25 collaborators of J. Sjef Verbeek. A scholar is included among the top collaborators of J. Sjef Verbeek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Sjef Verbeek. J. Sjef Verbeek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Braster, Rens, Marijn Bögels, Manfred Wuhrer, et al.. (2021). Afucosylated IgG Targets FcγRIV for Enhanced Tumor Therapy in Mice. Cancers. 13(10). 2372–2372. 7 indexed citations

Brouwers, Conny, Margot M. Linssen, Marcel Camps, et al.. (2020). Immunogenicity of rat-neu+ mouse mammary tumours determines the T cell-dependent therapeutic efficacy of anti-neu monoclonal antibody treatment. Scientific Reports. 10(1). 3933–3933. 5 indexed citations

Yu, Xiaojie, H.T. Claude Chan, Christine A. Penfold, et al.. (2020). Isotype Switching Converts Anti-CD40 Antagonism to Agonism to Elicit Potent Antitumor Activity. Cancer Cell. 37(6). 850–866.e7. 48 indexed citations

Koelink, Pim J., Felicia M. Bloemendaal, Bofeng Li, et al.. (2019). Anti-TNF therapy in IBD exerts its therapeutic effect through macrophage IL-10 signalling. Gut. 69(6). 1053–1063. 164 indexed citations

Breukel, Cor, Jill Claassens, Conny Brouwers, et al.. (2018). High FcγR Expression on Intratumoral Macrophages Enhances Tumor-Targeting Antibody Therapy. The Journal of Immunology. 201(12). 3741–3749. 7 indexed citations

Altıntaş, Işıl, Marjolein Sluijter, Sandra Verploegen, et al.. (2018). CD3-Bispecific Antibody Therapy Turns Solid Tumors into Inflammatory Sites but Does Not Install Protective Memory. Molecular Cancer Therapeutics. 18(2). 312–322. 61 indexed citations

Bloemendaal, Felicia M., Alon D. Levin, Manon E. Wildenberg, et al.. (2017). Anti–Tumor Necrosis Factor With a Glyco-Engineered Fc-Region Has Increased Efficacy in Mice With Colitis. Gastroenterology. 153(5). 1351–1362.e4. 27 indexed citations

Bieren, Julia Esser‐von, Ilaria Mosconi, Romain Guiet, et al.. (2013). Antibodies Trap Tissue Migrating Helminth Larvae and Prevent Tissue Damage by Driving IL-4Rα-Independent Alternative Differentiation of Macrophages. PLoS Pathogens. 9(11). e1003771–e1003771. 88 indexed citations

Beers, Stephen A., Ruth R. French, H.T. Claude Chan, et al.. (2010). Antigenic modulation limits the efficacy of anti-CD20 antibodies: implications for antibody selection. Blood. 115(25). 5191–5201. 241 indexed citations

10.

Mittal, Rahul, Sunil K. Sukumaran, M. Madan Babu, et al.. (2010). Fcγ Receptor I Alpha Chain (CD64) Expression in Macrophages Is Critical for the Onset of Meningitis by Escherichia coli K1. PLoS Pathogens. 6(11). e1001203–e1001203. 34 indexed citations

11.

Bergthaler, Andreas, Lukas Flatz, Admar Verschoor, et al.. (2009). Correction: Impaired Antibody Response Causes Persistence of Prototypic T Cell–Contained Virus. PLoS Biology. 7(8). 14 indexed citations

12.

Otten, Marielle A., Tom W.L. Groeneveld, Roelof Flierman, et al.. (2009). Both Complement and IgG Fc Receptors Are Required for Development of Attenuated Antiglomerular Basement Membrane Nephritis in Mice. The Journal of Immunology. 183(6). 3980–3988. 37 indexed citations

13.

Ding, Jin, Tingting Zhou, Huasong Zeng, et al.. (2008). Hyperacute Rejection by Anti-Gal IgG1, IgG2a, and IgG2b Is Dependent on Complement and Fc-γ Receptors. The Journal of Immunology. 180(1). 261–268. 22 indexed citations

14.

Baudino, Lucie, Falk Nimmerjahn, Yasuro Shinohara, et al.. (2008). Impact of a Three Amino Acid Deletion in the CH2 Domain of Murine IgG1 on Fc-Associated Effector Functions. The Journal of Immunology. 181(6). 4107–4112. 14 indexed citations

15.

Bos, Rinke, Suzanne van Duikeren, Thorbald van Hall, et al.. (2007). Characterization of Antigen-Specific Immune Responses Induced by Canarypox Virus Vaccines. The Journal of Immunology. 179(9). 6115–6122. 19 indexed citations

16.

Rodriguez, Wilfredo, Carolyn Mold, Milena Kataranovski, et al.. (2007). C-Reactive Protein-Mediated Suppression of Nephrotoxic Nephritis: Role of Macrophages, Complement, and Fcγ Receptors. The Journal of Immunology. 178(1). 530–538. 51 indexed citations

17.

Schuurhuis, Danita H., Nadine van Montfoort, Andreea Ioan‐Facsinay, et al.. (2006). Immune Complex-Loaded Dendritic Cells Are Superior to Soluble Immune Complexes as Antitumor Vaccine. The Journal of Immunology. 176(8). 4573–4580. 97 indexed citations

18.

Saeland, Eiríkur, Gestur Vidarsson, Jeanette H.W. Leusen, et al.. (2003). Central Role of Complement in Passive Protection by Human IgG1 and IgG2 Anti-pneumococcal Antibodies in Mice. The Journal of Immunology. 170(12). 6158–6164. 65 indexed citations

19.

Ji, Hong, Koichiro Ohmura, Umar Mahmood, et al.. (2002). Arthritis Critically Dependent on Innate Immune System Players. Immunity. 16(2). 157–168. 563 indexed citations breakdown →

20.

Baumann, Ulrich, Jörg Köhl, Thomas Tschernig, et al.. (2000). A Codominant Role of FcγRI/III and C5aR in the Reverse Arthus Reaction. The Journal of Immunology. 164(2). 1065–1070. 98 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact